Chemed (FRA:CXM) Other Current Liabilities: €107 Mil (As of Mar. 2026)


FRA:CXM Chemed Corp FRA:CXM
76 GF Score
Price €426.00
GF Value €571.46
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Chemed Other Current Liabilities?

Chemed FRA:CXM +0.47% 76 Other Current Liabilities is €107 Mil as of Mar. 2026. GuruFocus rates FRA:CXM with a GF Score™ of 76/100 and a GF Value™ of €571.46 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Chemed's other current liabilities for the quarter that ended in Mar. 2026 was €107 Mil.

Chemed's quarterly other current liabilities declined from Sep. 2025 (€115 Mil) to Dec. 2025 (€100 Mil) but then increased from Dec. 2025 (€100 Mil) to Mar. 2026 (€107 Mil).

Chemed's annual other current liabilities increased from Dec. 2023 (€126 Mil) to Dec. 2024 (€129 Mil) but then declined from Dec. 2024 (€129 Mil) to Dec. 2025 (€100 Mil).

Chemed Other Current Liabilities Related Terms

Chemed Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Chemed's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chemed Other Current Liabilities Chart

Chemed Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 119.15 137.67 126.15 128.88 100.11

Chemed Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 88.71 88.81 114.79 100.11 106.88
FRA:CXM
76GF Score
Chemed Corp FRA:CXM
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chemed Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of €107 Mil mean?
Chemed (FRA:CXM) has a Other Current Liabilities of €107 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Chemed.
Is Chemed's Other Current Liabilities too high?
Chemed's current Other Current Liabilities is €107 Mil. Overall, Chemed has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Chemed's Other Current Liabilities compare to PACS and LFST?
Chemed's Other Current Liabilities of €107 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Healthcare Providers & Services company?
A good Other Current Liabilities depends on the Healthcare Providers & Services industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Chemed. Chemed's current Other Current Liabilities is €107 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chemed stock overvalued right now?
Based on GuruFocus' analysis, Chemed (FRA:CXM) is currently considered Modestly Undervalued. The stock's GF Value™ is €571.46, compared to a current price of €426.00 — trading 25.5% below its estimated fair value. The current Other Current Liabilities is €107 Mil. Chemed's overall GF Score™ is 76/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Chemed (FRA:CXM), the current Other Current Liabilities is €107 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Chemed (FRA:CXM) Overvalued in 2026?

Based on GuruFocus' analysis, Chemed stock appears to be undervalued. The current stock price of €426.00 is trading 25.5% below its estimated GF Value™ of €571.46. GuruFocus considers Chemed to be Modestly Undervalued.

Key valuation signals for FRA:CXM:

  • Other Current Liabilities: €107 Mil
  • GF Value™: €571.46 vs. price of €426.00 (25.5% below fair value)
  • GF Score™: 76/100 with 6 warning signs

No single metric tells the full story. See the FRA:CXM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Chemed Business Description

Other Exchanges CHE:USA
Address 255 East Fifth Street, Suite 2600, Cincinnati, OH, USA, 45202-4726
Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. The company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.
76GF Score

Get the complete analysis for FRA:CXM

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€426.00
Price
€571.46
GF Value